Covenant Health

  • Cardiovascular Invasive Technologist (Registered)

    ID
    2784226
    Facility
    Morristown-Hamblen Health System
    Job Location
    US-TN-Morristown
    Department Name
    HEART CATH LAB
  • Overview

     

    MHACTV

     

    Cardiovascular Invasive Technologist (Registered)

    Part-Time, Day Shift, 48 hours per pay period

    STEMI call requirements; approximately every 3rd weekend and 2 days per week. May vary with staffing and vacation request.

     

    Position Summary: Provide assistance to the cardiologist or cardiac surgeon in performing diagnostic and interventional cardiac catheterization and angiography procedures, measuring cardiovascular parameters such as cardiac output, blood flow velocity, cardiovascular dynamics, cardiac electrophysiology parameters, intracardiac shunt detection, valve flow/valve area determinations, intracardiac pressure measurements, oximetry determination, cineangiocardiography, and the measurement and calculation of cardiac function indices. The technologist assists in all phases of catheterization procedure including insertion of the catheter, operation of various electronic instruments and calculation of hemodynamic data.

     

    Minimum Education: None specified; however, must be sufficient to meet the standards for achievement of the below indicated license and/or certification as required by the issuing authority.

     

    Minimum Experience: Three (3) years experience performing invasive cardiac catheterization procedures

     

    Licensure Requirement: Must hold current registration as a Registered Cardiovascular Invasive Specialist (RCIS), NASPExAM AP/EP, or ARRT -- preferably with a Cardiovascular-Interventional Technology (CV) category designation.  Current ACLS certification.  Annual training in infection control, fire, safety and CPR, lifting, and sterile technique

     

     

     

    Apply/Share

    Sorry the Share function is not working properly at this moment. Please refresh the page and try again later.
    Share on your newsfeed